Medical Dermatology
Make the Diagnosis
A healthy 36-year-old female presented with 4 days of itchy lesions on the right upper extremity
The patient had no systemic symptoms, but did have mild lymphadenopathy.
Latest News
Two phase 3 trials show benefits of dupilumab for prurigo nodularis
The results “support the involvement of type 2 cytokines in driving PN disease pathogenesis and the targeting of the IL-4/IL-13 axis as a novel...
Latest News
Beware the hidden allergens in nutritional supplements
A detailed history of supplement use is important, as it may reveal possible allergens as the cause of previously unidentified reactions.
Latest News
FMT in a pill: FDA approves second product to prevent C. diff recurrence
Clinicians now have two approved options for recurrent infections after antibiotic treatment.
Latest News
What are the main reasons patients sue dermatologists?
Of the cases studied, 56% were dismissed prior to trial, while 44% resulted in a judgment for the plaintiff.
Latest News
NPF provides guidance for virtual psoriasis visits
A National Psoriasis Foundation position paper addresses ongoing management of psoriatic disease via telemedicine.
Latest News
FDA clears first patch to treat axillary hyperhidrosis
Patients experienced a reduction in sweat that was maintained for 3 months or longer, according to trial results.
Make the Diagnosis
A 50-year-old White male presented with a 4- to 5-year history of progressively growing violaceous lesions on his left lower extremity
A 50-year-old presented with a 4- to 5-year history of progressively growing violaceous lesions on his left lower extremity, unresponsive to over-...
Latest News
What are the clinical implications of recent skin dysbiosis discoveries?
Activities that can contribute to alterations in skin flora or skin dysbiosis include topical application of steroids, antibiotics, retinoids,...
Latest News
Anifrolumab shows promise in refractory discoid lupus erythematosus
Anifrolumab improved symptoms and activity of DLE within 2 months in a study of eight women.
Latest News
FDA approves new Merkel cell carcinoma treatment
This marks the first regulatory approval for retifanlimab-dlwr, a PD-1 inhibitor.